By conducting differential gene expression and bio-informatics analyses on the tumor reversion cellular models, they identified more than 200 genes involved in the process of tumor reversion, and specifically TCTP (Translationally Controlled Tumor Protein / Translationally Controlled Tumour Protein ).
Laurent Susini moved to Oncology Clinical Research in 2007 to contribute in clinical early development of anti-cancer drugs.